Mackay Shields LLC’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-19,375
| Closed | -$887K | – | 1525 |
|
2020
Q3 | $887K | Buy |
19,375
+500
| +3% | +$22.9K | 0.01% | 1055 |
|
2020
Q2 | $947K | Sell |
18,875
-4,400
| -19% | -$221K | 0.01% | 1039 |
|
2020
Q1 | $1.2M | Buy |
23,275
+5,300
| +29% | +$273K | 0.01% | 885 |
|
2019
Q4 | $1.11M | Sell |
17,975
-2,800
| -13% | -$173K | 0.01% | 1046 |
|
2019
Q3 | $1.25M | Buy |
20,775
+2,800
| +16% | +$168K | 0.01% | 1062 |
|
2019
Q2 | $1.52M | Buy |
17,975
+11,183
| +165% | +$944K | 0.01% | 1006 |
|
2019
Q1 | $649K | Hold |
6,792
| – | – | ﹤0.01% | 1118 |
|
2018
Q4 | $481K | Buy |
6,792
+292
| +4% | +$20.7K | ﹤0.01% | 1152 |
|
2018
Q3 | $555K | Buy |
+6,500
| New | +$555K | ﹤0.01% | 988 |
|